Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

NCT01277601 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

751

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: TDF
DRUG: Peg-IFN

Sponsor

Gilead Sciences